A Study to Evaluate Safety, Acceptability, Pharmacokinetics, and ex Vivo Pharmacodynamics of TMC278 Long Acting Formulation in HIV-1 Seronegative Participants

Name: A Study to Evaluate Safety, Acceptability, Pharmacokinetics, and ex Vivo Pharmacodynamics of TMC278 Long Acting Formulation in HIV-1 Seronegative Participants
Published: 2012
License: Public Domain

Janssen Research & Development, LLC · 2012

ClinicalTrials.gov · Datasets · License: Public Domain · 2012

Open Source ↗

healthy hiv-1 pharmacokinetics

healthy, tmc278, human immunodeficiency virus type 1, hiv-1, pharmacokinetics, ex-vivo pharmacodynamics, interventional, phase1

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A Study to Evaluate Safety, Acceptability, Pharmacokinetics, and ex Vivo Pharmacodynamics of TMC278 Long Acting Formulation in HIV-1 Seronegative Participants

Related documents